History
  • No items yet
midpage
795 F. Supp. 2d 672
N.D. Ohio
2011
Read the full case

Background

  • This case is part of the Ortho Evra MDL centralized in ND Ohio under 28 U.S.C. § 1407.
  • Bower, a Michigan resident, used Ortho Evra from Feb–Mar 2005 and suffered a bilateral pulmonary embolism in Michigan.
  • Plaintiff filed suit in Sep 2009 in the District of Minnesota alleging multiple state-law claims.
  • The court has subject-matter jurisdiction under 28 U.S.C. § 1332.
  • Defendants moved for summary judgment; the court grants in part and denies in part.
  • Court addresses Michigan preemption of product liability and Minnesota consumer-protection claims.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether Michigan preemption bars product liability claims Bower argues Michigan § 600.2946(5) does not preempt her claims. Defendants argue preemption applies absent fraud/bribery exceptions, so Michigan claims are barred. Counts I–V precluded under Michigan preemption.
Whether Garcia, Wyeth, and Desiano control preemption analysis Plaintiff urges Wyeth overrides Garcia and Desiano allows failure-to-warn. Court adheres to Garcia and Wyeth; Desiano carries no precedential weight. Garcia and Wyeth control; Desiano not binding.
Scope of preemption within Michigan statute and its exceptions Exceptions (a)-(b) preemption analysis; Plaintiff seeks to avoid preemption. Statute preempts unless exceptions apply; evidence of fraud/bribery required. Exceptions do not save plaintiff’s Michigan product-liability claims; Counts I–V barred.
Viability of Minnesota claims (Counts VI–VIII) Minnesota statutes claim viability independent of Michigan preemption. Non-Minnesota claims governed by Michigan law; Minnesota claims may proceed. Summary judgment denied without prejudice as to Counts VI–VIII.

Key Cases Cited

  • Buckman Co. v. Pls' Legal Comm., 531 U.S. 341 (U.S. 2001) (fraud-on-FDA claims preempted by federal scheme)
  • Wyeth v. Levine, 555 U.S. 555 (U.S. 2009) (preemption not absolute; labeling changes and federal/state conflict centrale)
  • Garcia v. Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004) (preemption upheld for Michigan § 600.2946(5) unless exceptions apply)
  • Desiano v. Warner-Lambert Co., 467 F.3d 85 (2d Cir. 2007) (disagreed with Garcia on preemption scope; not controlling here)
  • In re Aredia and Zometa Products Liability Litigation, 352 Fed.Appx. 994 (6th Cir. 2009) ( Sixth Circuit reaffirmed Garcia-based stance; binding for preemption analysis)
  • Taylor v. SmithKline Beecham Corp., 468 Mich. 1 (Mich. 2003) (upheld Michigan’s preemption approach under § 600.2946(5))
  • White v. SmithKline Beecham Corp., 538 F. Supp. 2d 1023 (W.D. Mich. 2008) (district court applying Michigan preemption doctrine)
Read the full case

Case Details

Case Name: Bower v. Johnson & Johnson
Court Name: District Court, N.D. Ohio
Date Published: Jun 21, 2011
Citations: 795 F. Supp. 2d 672; 2011 U.S. Dist. LEXIS 65533; 2011 WL 2471577; Case 1:09 oe 40064
Docket Number: Case 1:09 oe 40064
Court Abbreviation: N.D. Ohio
Log In